Allergological Work‐Up in Cephalosporin Allergy Diagnosis and Delabelling: The Experience From Two European Allergy Centres
Allergy · 2025
DOI: 10.1111/all.70120 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Allergy, 2025. Verfasst von María Salas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Allergy Unit, Hospital Regional Universitario de Málaga, Málaga, Spain. Hauptthemen laut MEDLINE: Drug Hypersensitivity, Cephalosporins, Anti-Bacterial Agents. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Universidad de Málaga, Instituto de Salud Carlos III.
Abstract (Originalsprache)
Background
Diagnostic strategies for cephalosporin allergy are not well defined due to differences in inclusion criteria among studies and a lack of standardised diagnostic tests. Our aim was to describe the characteristics of patients with a suspicion of cephalosporin allergy and to analyse the role of in vivo tests.
Methods
Patients with suspected cephalosporin allergy were prospectively evaluated (2019–2023). Diagnosis was achieved using clinical history, skin tests ( STs ) and, if negative, drug provocation tests ( DPTs ). A randomised group of patients who tolerated DPT were retested by STs at 2–8 weeks.
Results
211 patients were evaluated, with 55.4% reporting IRs and 44.5% NIRs . Skin was involved in half of the patients reporting IRs and in all reporting NIRs ( p < 0.0001). Anaphylaxis was experienced by 18% and shock by 7.1%. The cephalosporin most commonly involved was cefuroxime (63.6%) ( p < 0.0001) in the Spanish cohort and cefazolin (51%) ( p < 0.0001) in the Italian one. Allergy was confirmed in 57.2% of patients reporting IRs (47% by STs and 9.4% by DPT ) and 14.9% of NIRs (5.3% by STs and 8.5% by DPT ). In the positive‐ ST group, the percentage of grade II and III reactions was higher ( p = 0.02) and the interval reaction‐study shorter ( p = 0.0007) than in negative‐ ST . Of the 48 patients retested, 1 (2.9%) who reported an IR and 1 (7.1%) who reported NIR resulted positive.
Conclusions
The patterns of cephalosporin allergy may differ across different regions, being STs and DPT useful for diagnosis. Further studies are needed to confirm the role of retesting, as well as to identify which patients would benefit most from this procedure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Allergy Unit, Hospital Regional Universitario de Málaga, Málaga, Spain.
- Allergy Research Group, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Málaga, Spain.
- Allergy Unit and Asthma Center, Verona University Hospital, Verona, Italy.
- Nanostructures for Diagnosing and Treatment of Allergic Diseases Laboratory, Andalusian Center for Nanomedicine and Biotechnology-BIONAND, Málaga, Spain.
- Departamento de Medicina, Facultad de Medicina, Universidad de Málaga, Málaga, Spain.
ORCID-Profile: María Salas, Inmaculada Doña, Marina Labella
Förderung
- Universidad de Málaga
- Instituto de Salud Carlos III
Zitieren
APA
Salas, M., Ghilarducci, A., Doña, I., Schiappoli, M., Labella, M., Dama, A., Olivieri, E., Torres, M. J., & Bonadonna, P. (2025). Allergological Work‐Up in Cephalosporin Allergy Diagnosis and Delabelling: The Experience From Two European Allergy Centres. Allergy. https://doi.org/10.1111/all.70120
Vancouver
Salas M, Ghilarducci A, Doña I, Schiappoli M, Labella M, Dama A, et al. Allergological Work‐Up in Cephalosporin Allergy Diagnosis and Delabelling: The Experience From Two European Allergy Centres. Allergy. 2025. doi:10.1111/all.70120
BibTeX
@article{Salas2025,
author = {Salas, María and Ghilarducci, Alessandro and Doña, Inmaculada and Schiappoli, Michele and Labella, Marina and Dama, Annarita and Olivieri, Elisa and Torres, María José and Bonadonna, Patrizia},
title = {Allergological Work‐Up in Cephalosporin Allergy Diagnosis and Delabelling: The Experience From Two European Allergy Centres},
journal = {Allergy},
year = {2025},
doi = {10.1111/all.70120}
}
EUVIMED